Figure 9.
Screening of the predicted pp220 peptide pools. Five pools (Pool A-E) of predicted SLA I-binding peptides from the ASFV (Georgia 2007/1) pp220 polyprotein (Table 2) were used to stimulate (A) PBMCs or (B) splenocytes isolated from pigs immunized with the Ad-pp220-ENABL® formulation, which were then evaluated for antigen-specific recall IFN-γ responses by EliSpot. Data is presented as Spot Forming Cells (SFC)/106 PBMCs or splenocytes for each pig. Medium alone served as the negative control, and the data shown is minus media background counts.